New & Noteworthy

Submit New & Noteworthy

September 2021

Lyme Disease Assay

QIAGEN

QIAGEN announces the launch of the LIAISON LymeDetect, a new diagnostic assay presented in partnership with DiaSorin, for the detection and early diagnosis of Lyme borreliosis on LIAISON XL and LIAISON XS platforms. In clinical studies, the assay showed, within 21 days from the first evidence of infection, a sensitivity of 74% versus that of other methods at 49%, while also demonstrating a diagnostic specificity of 100%.

Click here to view product detail on Findit.

Current Issue